Eligibility for Anti-Amyloid Treatment
Release Date:
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPub.org/Podcast for associated article links.
Eligibility for Anti-Amyloid Treatment